SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Tom Malone; Eloise Phillips; Lucy Rothwell; Lizzie Stafford; J. Kenneth Baillie; Malcolm G. Semple; Peter Openshaw; Gail Carson; Beatrice Alex; Petros Andrikopoulos; Benjamin Bach; William Barclay; Debby Bogaert; Meera Chand; Kanta Chechi; G Cooke; Ana da Silva Filipe; Thushan I. de Silva; Annemarie B Docherty; Gonçalo dos Santos Correia; Marc‐Emmanuel Dumas; Jake Dunning; Wanwisa Dejnirattisai; Jiandong Huo; Daming Zhou; Jiří Zahradník; Piyada Supasa; Chang Liu; Helen M. E. Duyvesteyn; Helen M. Ginn; Alexander J. Mentzer; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; Aiste Dijokaite-Guraliuc; Suman Khan; Ori Avinoam; Mohammad W. Bahar; Donal Skelly; Sandra Adele; Síle A. Johnson; Ali Amini; Thomas Ritter; Chris Mason; Christina Dold; Daniel Pan; Sara Assadi; Adam Bellass; Nicola Omo-Dare; David Koeckerling; Amy Flaxman; Daniel Jenkin; Parvinder K. Aley; Merryn Voysey; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Alves do Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid‐Corrêa; Marilda Mendonça Siqueira; Vicky L. Baillie; Natali Serafin; Gaurav Kwatra; Kelly da Silva; Shabir A. Madhi; Marta C. Nunes; Tariq Malik; Peter Openshaw; J. Kenneth Baillie; Malcolm G. Semple; Alain Townsend; Kuan-Ying A. Huang; Tiong Kit Tan; Miles W. Carroll; Paul Klenerman; Eleanor Barnes; Susanna Dunachie; Bede Constantinides; Hermione J. Webster; Derrick W. Crook; Andrew J. Pollard; Teresa Lambe; Neil G. Paterson; Mark A. Williams; David R. Hall; Elizabeth E. Fry; Juthathip Mongkolsapaya; Jingshan Ren; Gideon Schreiber; David I. Stuart; Gavin Screaton; Christopher P. Conlon; Alexandra Deeks; John Frater; Lisa Frending; Siobhan Gardiner; Anni Jämsén; Katie Jeffery

doi:10.1016/j.cell.2021.12.046

Keywords

VirologyBiologyNeutralizationAntibodyNeutralizing antibodyTiterMonoclonal antibodyImmune escapeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)MutationPandemicImmune systemVirusGeneticsGeneInfectious disease (medical specialty)Disease

Affiliated Institutions

Related Publications

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. García-Beltrán , Evan C. Lam , Kerri St. Denis +12 more

Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spi...

2021 Cell 1520 citations

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna K. Hansen , Alina Baum , Kristen E. Pascal +44 more

An antibody cocktail against SARS-CoV-2 There is an urgent focus on antibodies that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral spike and preve...

2020 Science 1398 citations

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers , Fangzhu Zhao , Deli Huang +31 more

Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neu...

2020 Science 1467 citations

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu , Lisa H. Tostanoski , Lauren Peter +51 more

Prototype DNA vaccines for SARS-CoV-2 The development of a vaccine to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent biomedical need. ...

2020 Science 1118 citations

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Yunlong Cao , Jing Wang , Fanchong Jian +27 more

Abstract The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies requires ...

2021 Nature 1997 citations

Publication Info

Year: 2022
Type: article
Volume: 185
Issue: 3
Pages: 467-484.e15
Citations: 998
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

998

OpenAlex

Cite This

APA Style

                            
                                
                                    Tom Malone, 
                                
                                    Eloise Phillips, 
                                
                                    Lucy Rothwell
                                
                                et al.
                            
                            (2022). 
                            SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. 
                            Cell
                            , 185
                            (3)
                            , 467-484.e15.
                            https://doi.org/10.1016/j.cell.2021.12.046
                        

Identifiers

DOI: 10.1016/j.cell.2021.12.046